NEWS & MEDIA

NEOVACS ISSUED NEW BROAD PATENT IN CHINA FOR IFNα KINOID

Paris, February 9, 2017 – Neovacs (Alternext Paris: ALNEV), a leader in active immunotherapy for the treatment of autoimmune diseases, today announces that it has been granted a new patent from the Chinese Patent Office (SIPO), titled: “Method of treatment of a disease related to the overexpression of IFNα”.

Download pdf